Диссертация (1140221), страница 25
Текст из файла (страница 25)
2006; 33:3:347-35660.Bloemenkamp KW, Rosendaal FR, Büller HR, Helmerhorst FM, Colly LP,Vandenbroucke JP. Risk of venous thrombosis with use of current low-dose oralcontraceptives is not explained by diagnostic suspicion and referral bias // ArchIntern Med 1999;159:65-7015761.Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, et al. Enhancement by factorV Leiden mutation of risk of deep-vein thrombosis associated with oralcontraceptives containing a third-generation progestogen // Lancet 1995; 346:1593–6.62.Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R.
Old and new risk factors forupper extremity deep venous thrombosis // J Thromb Haemost 2005;3:2471-863.Boekholdt S.M., Kramer M.H. Arterial thrombosis and the role of thrombophilia //Semin Thromb Hemost. 2007 Sep;33(6):588-96.64.Brandon H., James T, ElizaBeth G., Maureen J. L. Comparison of Rates of andCharges from Pregnancy Complications in Users of Extended and Cyclic CombinedOral Contraceptive (COC) Regimens: A Brief Report // Contraception. 2014 May;89(5): 396–399.65.Brenner B.
Inherited thrombophilia and pregnancy loss // Thromb Haemost.1999;82(2):634–640.66.Brenner B., Hoffman R., Blumenfeld Z. et al. Gestational outcome in thrombophilicwomen with recurrent pregnancy loss treated by enoxaparin // Thromb Haemost.2000 May;83(5):693-7.67.Brill-Edwards P., Ginsberg J.S., Gent M. et al; Recurrence of Clot in ThisPregnancy Study Group.
Safety of withholding heparin in pregnant women with ahistory of venous thromboembolism // N Engl J Med. 2000 Nov 16;343(20):143944.68.Brittany M Charlton, Ditte Molgaard, Henrik Svanstrom – Maternal use of oralcontraceptives and risk of birth defects in Denmark: prospective, nationwide cohortstudy // BMJ 2016; 352:h671269.Bujold E., Roberge S., Lacasse Y. et al. Prevention of preeclampsia and intrauterinegrowth restriction with aspirin started in early pregnancy: a meta-analysis // ObstetGynecol.
2010 Aug;116(2 Pt 1):402-14.70. Cameron C. Trenor III, MD, Richard J. Chung, MD, Alan D. Michelson, MD Hormonal contraception and thrombotic risk: a multidisciplinary approach //Pediatrics. 2011 Feb; 127 (2): 347–35715871. Cande V. A., Morgan R. P., Celeste De M. Associations Between TwoPolymorphisms in the Methylenetetrahydrofolate Reductase Gene and PlacentalAbruption // Am J Obstet Gynecol. 2007 Oct; 197(4): 385.e1–385.e7.72.Carbillon L. Pregnancy is an essential spontaneous screening stress test for the riskof early stroke in women // Stroke.
2008 Aug;39(8):e13873.Carmel R., Jacobsen D. W. Homocysteine in Health and Disease // Cambridge:University Press, 2001. — 500 p.74.Cattaneo M. Hyperhomocysteinemia and venous thromboembolism // SeminThromb Hemost. 2006 Oct;32(7):716-23.75.Cervera R., Piette J.C., Font J. et al.; Euro-Phospholipid Project Group.Antiphospholipid syndrome: clinical and immunologic manifestations and patternsof disease expression in a cohort of 1,000 patients // Arthritis Rheum.
2002Apr;46(4):1019-27.76.Chen М., Culwell К.– Contraception for women with medical problems // Glob.libr. women's med., (ISSN: 1756-2228) 2015; DOI 10.3843/GLOWM.1038277.Coomarasamy A., Honest H., Papaioannou S. et al. Aspirin for prevention ofpreeclampsia in women with historical risk factors: a systematic review // ObstetGynecol. 2003 Jun;101(6):1319-32.78.Coppola A., Davi G., De Stefano V.
et al. Homocysteine, coagulation, plateletfunction, and thrombosis // Semin Thromb Hemost. 2000;26(3):243-5479. Corand J., Hovellou M.H., Van Dreden P., Lecompte Т., Samama M. Thrombosisand pregnancy in congenital deficiencies in antithrombin III, protein С or protein S:study of 78 women. // Thromb Haemost 1990; 63: 319.80.Coulam C.B., Wallis D., Weinstein J., Jeyendran R.S. Comparison of thrombophilicgene mutations among patients experiencing recurrent miscarriage and deep veinthrombosis // Am J Reprod Immunol. 2008 Nov;60(5):426-31.81.De Stefano V., Martinelli I., Rossi E. et al. The risk of recurrent venousthromboembolism in pregnancy and puerperium without antithromboticprophylaxis // Br J Haematol.
2006 Nov;135(3):386-91.15982.De Stefano V., Rossi E., Paciaroni K., Leone G. Screening for inheritedthrombophilia: indications and therapeutic implications // Haematologica. 2002Oct;87(10):1095-10883.Den Heijer M., Lewington S., Clarke R. Homocysteine, MTHFR and risk of venousthrombosis: a meta-analysis of published epidemiological studies // J ThrombHaemost. 2005 Feb;3(2):292-9.84.Dhont М. – History of hormonal contraception // The European Journal ofContraception & Reproductive Health Care Volume 15, 2010 - Issue sup285.Dinger J., Assmann A., Möhner S., Minh T.D.
- Risk of venous thromboembolismand the use of dienogest- and drospirenone-containing oral contraceptives: resultsfrom a German case-control study // J Fam Plann Reprod Health Care 2010 36: 123129 doi: 10.1783/14711891079174941686.Dinger J.C., Heinemann L.A., Kühl-Habich D. - The safety of a drospirenonecontaining oral contraceptive: final results from the European Active SurveillanceStudy on oral contraceptives based on 142,475 women-years of observation //Contraception. 2007 May;75(5):344-54. Epub 2007 Feb 23.87.Duhl A.J., Paidas M.J., Ural S.H. et al.; Pregnancy and Thrombosis Working Group.Antithrombotic therapy and pregnancy: consensus report and recommendations forprevention and treatment of venous thromboembolism and adverse pregnancyoutcomes //Am J Obstet Gynecol.
2007 Nov;197(5):457.e1-21.88.Eichinger S. D-dimer testing in pregnancy. // Semin Vasc Med. 2005 Nov;5(4):3758.89.Eldibany M.M., Caprini J.A. Hyperhomocysteinemia and thrombosis: an overview//Arch Pathol Lab Med. 2007 Jun;131(6):872-84.90.Farley T.M, Collins J, Schlesselman JJ. - Hormonal contraception and risk ofcardiovascular disease. An international perspective.
// Contraception 1998;57:211-230.91.Farmer R.D., Lawrenson R.A., Thompson C.R., Kennedy J.G., Hambleton I.R.Population-based study of risk of venous thromboembolism associated with variousoral contraceptives // Lancet 1997;349:83-8.16092.Folkeringa N., Brouwer J.L., Korteweg F.J. et al. High risk of pregnancy-relatedvenous thromboembolism in women with multiple thrombophilic defects // Br JHaematol. 2007 Jul;138(1):110-6.93. Furness D.L., Fenech M.F., Khong Y.T.
One-carbon metabolism enzymepolymorphisms and uteroplacental insufficiency // Am J Obstet Gynecol. 2008Sep;199(3): 276.e1-8.94.Gerhardt A., Scharf R.E., Beckmann M.W. et al. Prothrombin and factor Vmutations in women with a history of thrombosis during pregnancy and thepuerperium // N Engl J Med. 2000 Feb 10;342(6):374-80.95. Glueck C.J., Phillips H., Cameron D., Wang P. The 4G/4G polymorphism of thehypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent riskfactor for serious pregnancy complications // Metabolism. 2000 Jul; 49(7):845-52.96.Govindaiah V., Naushad S.M., Prabhakara K. et al. Association of parentalhyperhomocysteinemiaandC677TMethylenetetrahydrofolatereductase(MTHFR) polymorphism with recurrent pregnancy loss // Clin Biochem.
2009Mar;42(4-5):380-6.97.GreerI.A.,Nelson-PiercyC.Low-molecular-weightheparinsforthromboprophylaxis and treatment of venous thromboembolism in pregnancy: asystematic review of safety and efficacy // Blood. 2005 Jul 15;106(2):401-7.98. Grimes, David A. MD; Stuart, Gretchen S. MD - Screening Women for OralContraception: Can Family History Identify Inherited Thrombophilias? // Obstetrics& Gynecology: October 2012 - Volume 120 (4) - p 889–89599.Gris J.C., Mercier E., Quéré I. et al. Low-molecular-weight heparin versus low-doseaspirin in women with one fetal loss and a constitutional thrombophilic disorder //Blood.
2004 May 15;103(10):3695-9.100. Gris J.C., Quéré I., Monpeyroux F., Mercier E. et al. Case-control study of thefrequency of thrombophilic disorders in couples with late foetal loss and nothrombotic antecedent--the Nîmes Obstetricians and Haematologists Study5(NOHA5) // Thromb Haemost. 1999 Jun;81(6):891-9.161101. Heit J.A., Silverstein M.D., Mohr D.N.
et al. Risk factors for deep veinthrombosis and pulmonary embolism: a population-based case-control study // ArchIntern Med. 2000 Mar 27;160(6):809-15.102. Henke P.K. All deep vein thrombosis patients should be routinely screened forthrombophilia // Dis Mon. 2010 Oct;56(10):563-8.103. Huang T., Yuan G., Zhang Z.
et al. Cardiovascular pathogenesis inhyperhomocysteinemia // Asia Pac J Clin Nutr. 2008;17(1):8-16.104. James A.H., Brancazio L.R., Price T. Aspirin and reproductive outcomes //Obstet Gynecol Surv. 2008 Jan;63(1):49-57.105. JamesA.H.,JamisonM.G.,BrancazioL.R.,MyersE.R.Venousthromboembolism during pregnancy and the postpartum period: incidence, riskfactors, and mortality // Am J Obstet Gynecol. 2006 May;194(5):1311-5.106.
Jeanine F. Carbone MD, Roxane Rampersad MD - Prenatal Screening forThrombophilias: Indications and Controversies // Clinics in Laboratory MedicineVol 30 (3), September 2010, 747–760107. Jensen J.T., Burke A.E., Barnhart K.T. et al. Effects of switching from oral totransdermal or transvaginal contraception on markers of thrombosis //Contraception.
2008 Dec;78(6):451-8.108. Jeremy A. Holtsclaw. Progress Towards the Total Synthesis of Desogestrel andthe Development of a New Chiral Dihydroimidazol-2-ylidene Ligand // Universityof Michigan. 2007 - p. 25.109. Jick H., Jick S.S., Gurewich V., et al. Risk of idiopathic cardiovascular deathand nonfatal venous thromboembolism in women using oral contraceptives withdiffering progestagen components // Lancet 1995;346:1589–93.110.Jurgen Dinger, Anita Assmann, Sabine Mohner – Risk of venousthromboembolism and the use of dienogest- and drospirenone-containing oralcontraceptives: results from a German case-control study // J Fam Plann ReprodHealth Care 2010; 36 (3): 123-129162111.
Karp Leaf R., Jean M. Connors - The Role of Anticoagulants in the Preventionof Pregnancy Complications // Clinical and Applied Thrombosis/Hemostasis Vol23, Issue 2, 2017112. Keijzer M.B., den Heijer M., Blom H.J. et al. Interaction betweenhyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR)and inherited thrombophilic factors in recurrent venous thrombosis // ThrombHaemost. 2002 Nov;88(5):723-8.113. Kelly P.J., Rosand J., Kistler J.P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
